发明公开
- 专利标题： QUINAZOLINONE T-TYPE CALCIUM CHANNEL ANTAGONISTS
- 专利标题（中）： 钙通道拮抗剂TYPE喹唑啉酮ŧ
-
申请号： EP08779992.0申请日： 2008-07-07
-
公开(公告)号： EP2175725A1公开(公告)日： 2010-04-21
- 发明人: BARROW, James, C. , YANG, Zhi-Qiang
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： 126 East Lincoln Avenue Rahway, NJ 07065 US
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： 126 East Lincoln Avenue Rahway, NJ 07065 US
- 代理机构： Buchan, Gavin MacNicol
- 优先权： US958944P 20070710
- 国际公布： WO2009009015 20090115
- 主分类号： A01N43/54
- IPC分类号： A01N43/54 ; A61K31/517
摘要：
The present invention is directed to quinazolinone compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
信息查询
IPC分类:
